SIRT1 and colorectal cancer: Co-delivery of 5-FU and miR-34a(m) could achieve synergistic effects on tumor suppression in vitro and in vivo by enhancing anti-colorectal cancer (CRC) activity of 5-FU via silencing sirt1 expression and suppressing CRC cell migration by targeting CD44 [29].